Churchill Capital Corp XI (CCXI)

Churchill Capital Corp XI (CCXI) is a Shell Companies company in the Financial Services sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $572M; returns 1 day -0.0%, 1 week -3.8%.

ChemoCentryx Inc. is a biopharmaceutical company specializing in orally administered small-molecule therapeutics targeting the chemokine and chemoattractant systems to treat autoimmune diseases, inflammatory disorders, and cancer. The company was acquired by Amgen (AMGN) in October 2022 for approximately $3.7 billion, and currently operates as a wholly-owned subsidiary.

CCXI financial model: income statement, cash flow and balance sheet